Erysipelas primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Primary prevention of Erysipelas involves preventing pathogenesis from [[streptococcal]] infection, as well as preventing the original [[streptococcal]] infection. | |||
==Primary Prevention== | ==Primary Prevention== | ||
*Primary prevention of Erysipelas involves preventing pathogenesis from [[streptococcal]] infection. | *Primary prevention of Erysipelas involves preventing pathogenesis from [[streptococcal]] infection. | ||
**Avoiding [[cutaneous]] barrier disruptions, such as cuts, abrasions, or [[ulcers]].<ref name="pmid24884840">{{cite journal |vauthors=Inghammar M, Rasmussen M, Linder A |title=Recurrent erysipelas--risk factors and clinical presentation |journal=BMC Infect. Dis. |volume=14 |issue= |pages=270 |year=2014 |pmid=24884840 |pmc=4033615 |doi=10.1186/1471-2334-14-270 |url=}}</ref> | |||
**Maintaining a [[BMI]] below [[overweight]] and [[obesity]] through lifestyle factors, including [[diet]] and [[exercise]]. | |||
**[[Prophylactic]] administration of [[penicillin]] if [[streptococcal]] infection is confirmed.<ref name="pmid21910701">{{cite journal |vauthors=Thomas K, Crook A, Foster K, Mason J, Chalmers J, Bourke J, Ferguson A, Level N, Nunn A, Williams H |title=Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial |journal=Br. J. Dermatol. |volume=166 |issue=1 |pages=169–78 |year=2012 |pmid=21910701 |pmc=3494300 |doi=10.1111/j.1365-2133.2011.10586.x |url=}}</ref> | |||
*Measures to prevent [[streptoccocal]] infection are also important to prevent Erysipelas.<ref name="urlGroup A Strep | Questions and Answers | GAS | CDC">{{cite web |url=http://www.cdc.gov/groupastrep/about/faqs.html |title=Group A Strep | Questions and Answers | GAS | CDC |format= |work= |accessdate=}}</ref> | |||
**Avoiding direct contact with infected individuals. | |||
**Practicing good hygiene, such as hand-washing. | |||
**Avoiding [[cutaneous]] disruptions. | |||
**Maintaining [[immunocompetence]]. | |||
==References== | ==References== | ||
Revision as of 17:39, 15 September 2016
|
Erysipelas Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Erysipelas primary prevention On the Web |
|
American Roentgen Ray Society Images of Erysipelas primary prevention |
|
Risk calculators and risk factors for Erysipelas primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
Overview
Primary prevention of Erysipelas involves preventing pathogenesis from streptococcal infection, as well as preventing the original streptococcal infection.
Primary Prevention
- Primary prevention of Erysipelas involves preventing pathogenesis from streptococcal infection.
- Avoiding cutaneous barrier disruptions, such as cuts, abrasions, or ulcers.[1]
- Maintaining a BMI below overweight and obesity through lifestyle factors, including diet and exercise.
- Prophylactic administration of penicillin if streptococcal infection is confirmed.[2]
- Measures to prevent streptoccocal infection are also important to prevent Erysipelas.[3]
- Avoiding direct contact with infected individuals.
- Practicing good hygiene, such as hand-washing.
- Avoiding cutaneous disruptions.
- Maintaining immunocompetence.
References
- ↑ Inghammar M, Rasmussen M, Linder A (2014). "Recurrent erysipelas--risk factors and clinical presentation". BMC Infect. Dis. 14: 270. doi:10.1186/1471-2334-14-270. PMC 4033615. PMID 24884840.
- ↑ Thomas K, Crook A, Foster K, Mason J, Chalmers J, Bourke J, Ferguson A, Level N, Nunn A, Williams H (2012). "Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial". Br. J. Dermatol. 166 (1): 169–78. doi:10.1111/j.1365-2133.2011.10586.x. PMC 3494300. PMID 21910701.
- ↑ "Group A Strep | Questions and Answers | GAS | CDC".